Latest Period
Q2 2026
Security Snapshot
BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) Institutional Ownership
CUSIP: 09077B104
13F Institutional Holders and Ownership History from Q4 2020 to Q2 2026
Institutions Reporting
1
Shares (Excl. Options)
108,126
Price
$4.14
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stocks, par value $0,0001 per share
- Symbol
- BCAB on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 108,126
- Total 13F value
- $447,645
- Portfolio coverage rank
- 0%
- Share change
- -15,270,885
- Value change
- -$23,539,038
- Number of holders
- 1
- Shares outstanding
- 58,548,563
- SEC-reported price per share
- $4.14
- Insider filing price
- $4.14
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- BCAB - BioAtla, Inc. - Common Stocks, par value $0,0001 per share is tracked under CUSIP 09077B104.
- 1 institution reported positions in Q2 2026.
- 5 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 34 to 1 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $2,469,338 to $447,645.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 1 institution filings for Q2 2026.
Security key
09077B104
Latest holder period
Q2 2026
13F holders
1
13D/G owners
5
CIK / CUSIP context first
Open Q2 2026 holders
BCAB full holder history
BioAtla, Inc. SEC filings
BioAtla, Inc. company facts
BioAtla, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 09077B104:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
5
Security
BCAB
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 7.7% | -22% | $2,129,415 | -$1,104,235 | 4,839,579 | -34% | Highbridge Capital Management, LLC | 31 Mar 2025 |
| ACORN BIOVENTURES, L.P. | 8.3% | $2,127,449 | 4,835,111 | Anders Hove | 15 May 2025 | |||
| SHORT JAY M PHD | 6.6% | $1,700,884 | 3,865,646 | Jay M. Short | 31 Dec 2024 | |||
| OPOKA INVESTMENT FUND Co | 4.8% | -22% | $1,933,227 | -$507,296 | 2,810,331 | -21% | OPOKA INVESTMENT FUND Co | 09 Jul 2025 |
| MILLENNIUM MANAGEMENT LLC | 1.9% | $482,067 | 1,095,606 | Millennium Management LLC | 31 Dec 2024 |
As of 30 Jun 2026, 1 institutional investors reported holding 108,126 shares of BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB). This represents 0.18% of the company’s total 58,548,563 outstanding shares.
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
23
Latest
Q2 2026
Rows shown
1-23 of 23
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 108,126 | $447,645 | -$23,539,038 | $4.14 | 1 |
| 2026 Q1 | 15,379,483 | $2,469,338 | -$141,023 | $0.16 | 34 |
| 2025 Q4 | 13,178,637 | $7,494,979 | -$262,374 | $0.57 | 40 |
| 2025 Q3 | 13,349,032 | $9,190,012 | +$218,760 | $0.69 | 43 |
| 2025 Q2 | 13,168,921 | $5,214,805 | -$178,456 | $0.40 | 39 |
| 2025 Q1 | 13,676,589 | $4,757,169 | -$6,041,757 | $0.35 | 40 |
| 2024 Q4 | 24,014,047 | $14,192,960 | -$3,984,785 | $0.59 | 67 |
| 2024 Q3 | 17,681,418 | $31,044,305 | -$6,375,131 | $1.76 | 63 |
| 2024 Q2 | 22,134,924 | $30,397,774 | -$9,819,957 | $1.37 | 78 |
| 2024 Q1 | 25,353,603 | $87,226,850 | -$3,078,466 | $3.44 | 83 |
| 2023 Q4 | 27,002,533 | $66,550,242 | -$6,102,978 | $2.46 | 79 |
| 2023 Q3 | 29,893,256 | $50,818,372 | -$3,978,003 | $1.70 | 80 |
| 2023 Q2 | 32,003,208 | $96,009,836 | -$889,082 | $3.00 | 86 |
| 2023 Q1 | 32,818,307 | $87,622,240 | -$35,920,780 | $2.68 | 79 |
| 2022 Q4 | 33,849,374 | $279,248,047 | +$75,723,026 | $8.25 | 88 |
| 2022 Q3 | 24,872,441 | $191,538,348 | +$24,104,114 | $7.70 | 66 |
| 2022 Q2 | 23,517,118 | $67,049,000 | -$8,813,651 | $2.85 | 71 |
| 2022 Q1 | 25,528,713 | $127,715,000 | -$39,588,884 | $5.00 | 91 |
| 2021 Q4 | 26,409,935 | $518,424,807 | +$9,459,769 | $19.63 | 79 |
| 2021 Q3 | 25,357,996 | $746,373,968 | +$120,415,617 | $29.44 | 83 |
| 2021 Q2 | 21,165,507 | $896,994,925 | +$89,307,130 | $42.38 | 73 |
| 2021 Q1 | 19,002,884 | $964,589,936 | +$187,867,257 | $50.84 | 62 |
| 2020 Q4 | 15,664,281 | $530,219,000 | +$530,219,000 | $34.01 | 53 |